Repro-Med Systems (OTCMKTS:REPR) Director Joseph M. Jr. Manko purchased 38,490 shares of the business’s stock in a transaction dated Friday, May 25th. The shares were purchased at an average cost of $1.32 per share, for a total transaction of $50,806.80. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of Repro-Med Systems stock remained flat at $$1.35 during midday trading on Friday. The company had a trading volume of 55,998 shares, compared to its average volume of 36,143. Repro-Med Systems has a one year low of $0.34 and a one year high of $1.50.
About Repro-Med Systems
Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.
Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with MarketBeat.com's FREE daily email newsletter.